Ruzbeh Toussi, DO
Pain Medicine · Lynchburg, VANPI 1992021216
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (46.1%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Medtronic at 52.2% of the total. Reporting peaked in 2021 at $1,942 and has fallen 80.6% since, to $377 in 2024.
Across 70 payments — averaging $70.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Vertos Medical, Inc.$1K
- Boston Scientific$440
- Nevro Corp.$141
- Abbott$129
- AbbVie$113
- plus $278 from 10 others
What the payments were for
- Speaking & faculty fees$1,50530%
- Travel & lodging$1,17524%
- Food & beverage$2,28846%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 30 | $2,592 |
| Vertos Medical, Inc. | 6 | $1,276 |
| Boston Scientific | 13 | $440 |
| Nevro Corp. | 1 | $141 |
| Abbott | 1 | $129 |
| AbbVie | 5 | $113 |
| Fidia Pharma USA Inc. | 2 | $67 |
| Novartis | 1 | $49 |
| Bioventus LLC | 2 | $25 |
| Si-bone, Inc. | 1 | $23 |
| Kaleo, Inc. | 2 | $23 |
| Pfizer | 2 | $22 |
| Tersera Therapeutics LLC | 1 | $20 |
| Ferring Pharmaceuticals Inc. | 1 | $19 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
| SPR Therapeutics, Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- mild Device Kit$1,100
- INTELLIS ADAPTIVESTIM$406
- INTELLIS$190
- Omnia$141
- VECTRIS$139
- PROCLAIM$129
How this compares
$4,969 in reported general payments places this provider in the 75th percentile of 150 pain medicine providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tizanidine Hcl | 385 | $4,201 |
| Gabapentin | 502 | $4,021 |
| Calcitonin-SalmonCalcitonin,salmon,synthetic | 57 | $3,386 |
| Pregabalin | 117 | $2,848 |
| Diclofenac Sodium | 247 | $2,558 |
| Celecoxib | 72 | $1,660 |
| Methylprednisolone | 234 | $1,619 |
| Lidocaine | 17 | $1,225 |
| Cyclobenzaprine Hcl | 101 | $628 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 48 | $553 |
| Methocarbamol | 47 | $375 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 35 | $332 |
| Duloxetine Hcl | 26 | $316 |
| Baclofen | 25 | $241 |
| Meloxicam | 45 | $220 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Lynchburg
- Reza SalajeghehLynchburg$4K
- Karen BurnhamLynchburg$4K
- Edward MetzgerLynchburg$3K
- Matthew RileyLynchburg$2K
- Sebastian KsionskiLynchburg$2K
- Chheany UngRoanoke$198K
- Daniel KendallMc Lean$100K
- Steven GershonVirginia Beach$78K
- Jared DavisFishersville$45K
- Nameer HaiderWoodbridge$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.